Equity (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| Stockholders' Equity Note [Abstract] |
|
| Schedule of stock-based compensation expense |
Share-based compensation expenses for equity-classified share options, restricted share units (“RSUs”) and performance-based restricted share units (“PSUs”), in the aggregate, were allocated as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
|
2026 |
|
2025 |
|
|
|
|
|
|
(U.S. $ in thousands) |
|
|
| Cost of revenues |
|
$ |
661 |
|
|
$ |
708 |
|
|
|
|
|
| Research and development, net |
|
1,072 |
|
|
1,240 |
|
|
|
|
|
| Selling, general and administrative |
|
3,552 |
|
|
4,265 |
|
|
|
|
|
Total share-based compensation expenses |
|
$ |
5,285 |
|
|
$ |
6,213 |
|
|
|
|
|
|
| Schedule of stock option activity |
A summary of the Company’s share option activity for the three months ended March 31, 2026 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Options |
|
Weighted Average Exercise Price |
Options outstanding as of January 1, 2026 |
|
1,224,196 |
|
|
17.67 |
|
|
|
|
|
|
|
|
|
|
|
| Forfeited |
|
(50,550) |
|
|
24.27 |
|
Options outstanding as of March 31, 2026 |
|
1,173,646 |
|
|
17.38 |
|
Options exercisable as of March 31, 2026 |
|
1,134,042 |
|
|
17.59 |
|
|
| Schedule of RSUs and PSUs activity |
A summary of the Company’s RSUs and PSUs activity for the three months ended March 31, 2026 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of RSUs and PSUs |
|
Weighted Average Grant Date Fair Value |
Unvested as of January 1, 2026 |
|
4,726,135 |
|
|
10.84 |
|
| Granted |
|
2,061,768 |
|
|
9.66 |
|
| Vested |
|
(737,424) |
|
|
11.83 |
|
| Forfeited |
|
(107,180) |
|
|
10.99 |
|
Unvested as of March 31, 2026 |
|
5,943,299 |
|
|
10.31 |
|
|
| Schedule of accumulated other comprehensive loss |
The following tables present the changes in the components of accumulated other comprehensive income (loss), net of taxes, for the three months ended March 31, 2026 and 2025, respectively:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2026 |
|
Net Unrealized Gain (Loss) on Cash Flow Hedges |
|
Foreign Currency Translation Adjustments |
|
Total |
|
(U.S. $ in thousands) |
Balance as of January 1, 2026 |
$ |
(624) |
|
|
$ |
(5,573) |
|
|
$ |
(6,197) |
|
| Other comprehensive income (loss) before reclassifications |
1,723 |
|
|
(1,323) |
|
|
400 |
|
| Amounts reclassified from accumulated other comprehensive loss |
846 |
|
|
— |
|
|
846 |
|
| Other comprehensive income (loss) |
2,569 |
|
|
(1,323) |
|
|
1,246 |
|
| Balance as of March 31, 2026 |
$ |
1,945 |
|
|
$ |
(6,896) |
|
|
$ |
(4,951) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2025 |
|
Net Unrealized Gain (Loss) on Cash Flow Hedges |
|
Foreign Currency Translation Adjustments |
|
Total |
|
(U.S. $ in thousands) |
Balance as of January 1, 2025 |
$ |
4,907 |
|
|
$ |
(12,938) |
|
|
$ |
(8,031) |
|
Other comprehensive income (loss) before reclassifications |
(1,778) |
|
|
1,726 |
|
|
(52) |
|
| Amounts reclassified from accumulated other comprehensive loss |
(1,257) |
|
|
— |
|
|
(1,257) |
|
| Other comprehensive income (loss) |
(3,035) |
|
|
1,726 |
|
|
(1,309) |
|
| Balance as of March 31, 2025 |
$ |
1,872 |
|
|
$ |
(11,212) |
|
|
$ |
(9,340) |
|
|